![]() |
市場調査レポート
商品コード
1541656
医療用ポリマーの市場レポート:製品タイプ、用途、地域別、2024~2032年Medical Polymers Market Report by Product Type (Medical Resins and Fibers, Medical Elastomers, Biodegradable Plastics), Application (Medical Equipment and Devices, Medical Packaging, and Others), and Region 2024-2032 |
||||||
カスタマイズ可能
|
医療用ポリマーの市場レポート:製品タイプ、用途、地域別、2024~2032年 |
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2~3営業日
|
世界の医療用ポリマーの市場規模は2023年に219億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに391億米ドルに達し、2024~2032年の間に6.5%の成長率(CAGR)を示すと予測しています。
医療用ポリマーは、再生医療や組織工学における薬剤の製造に使用されるバルク材料、コーティング、医薬品ナノキャリアで構成されます。医療用ポリマーは、汎用性、強度、柔軟性、生分解性、生体適合性、滅菌安定性、耐疲労性、耐熱性、耐電性を備えています。現在、複数のメーカーが、分子量、架橋度、結晶化度、共重合体やブレンド、生物活性表面官能基の追加などを調整した、さまざまなタイプの医療用ポリマーを開発しています。さらに、新しく革新的な医療機器に対する需要の高まりは、機器の開発と持続可能性を支える医療用ポリマーの必要性を世界的に高めています。
コロナウイルス感染症(COVID-19)の診断と治療のために、綿棒、医療機器、使い捨てマスク、個人防護具(PPE)のニーズが高まっていることは、医療用ポリマーの需要を押し上げている重要な要因の一つです。これとは別に、感染症、慢性疾患、心血管疾患、その他の慢性疾患の有病率の増加が高度医療機器の採用を後押ししており、これが市場の成長に寄与しています。さらに、各国政府は医療インフラを改善するため、医療研究開発(R&D)プロジェクトに資金を提供しています。このほか、高齢者人口の増加や事故件数の増加による臓器移植のニーズの高まりが市場を牽引しています。さらに、医療ツーリズムの新たな動向や在宅医療サービスの人気の高まりが、市場の成長を促進しています。また、市場の大手企業は、新しく洗練されたバイオポリマーの導入に注力しており、整形外科用安定化材料や血管ステントへの医療用ポリマーの応用が強化されると予測されます。
The global medical polymers market size reached US$ 21.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.1 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032.
Medical polymers comprise bulk materials, coatings, and pharmaceutical nano-carriers used for making drugs in regenerative medicine and tissue engineering. They offer versatility, strength, flexibility, biodegradability, biocompatibility, sterilization stability, and fatigue, heat, and electrical resistance. Several manufacturers are currently proving different types of medical polymers with adjusted molecular weight, crosslinking and crystallization degrees, copolymers and blends, and additional bioactive surface functionalization. Moreover, the growing demand for new and innovative medical devices is escalating the need for medical polymers worldwide to support device development and sustainability.
The rising need for swabs, medical devices, disposable masks, and personal protective equipment (PPE) to diagnose and treat individuals with coronavirus disease (COVID-19) represents one of the key factors impelling the demand for medical polymers. Apart from this, the increasing prevalence of infectious, chronic, cardiovascular, and other chronic diseases is propelling the adoption of advanced medical devices, which, in turn, is contributing to the market growth. Additionally, governments of numerous countries are financing medical research and development (R&D) projects to improve healthcare infrastructure. Besides this, the increasing need for organ transplantation due to the growing geriatric population and escalating number of accidents is driving the market. Furthermore, the emerging trend of medical tourism and the increasing popularity of home healthcare services are promoting the market growth. The leading market players are also focusing on introducing new and sophisticated biopolymers, which is projected to enhance the application of medical polymers in orthopedic stabilizing materials and vascular stents.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical polymers market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type and application.
Medical Resins and Fibers
Polyvinyl Chloride
Polypropylene
Polyethylene
Polystyrene
Others
Medical Elastomers
Styrene Block Copolymer
Rubber Latex
Others
Biodegradable Plastics
Medical Equipment and Devices
Medical Packaging
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Celanese Corporation, Covestro AG, DuPont, Eastman Chemical Company, Evonik Industries AG, Exxon Mobil Corporation, Huizhou Foryou Medical Device Co. Ltd., Kraton Corporation and Solvay S.A.